Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Non-Current Deffered Revenue (2019 - 2025)

Historic Non-Current Deffered Revenue for Legend Biotech (LEGN) over the last 7 years, with Q2 2025 value amounting to -$277000.0.

  • Legend Biotech's Non-Current Deffered Revenue rose 546.08% to -$277000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was -$277000.0, marking a year-over-year increase of 546.08%. This contributed to the annual value of $48.0 million for FY2023, which is 1572280.13% up from last year.
  • As of Q2 2025, Legend Biotech's Non-Current Deffered Revenue stood at -$277000.0, which was up 546.08% from -$134000.0 recorded in Q1 2025.
  • Legend Biotech's Non-Current Deffered Revenue's 5-year high stood at $48.0 million during Q4 2023, with a 5-year trough of -$484000.0 in Q3 2023.
  • Over the past 5 years, Legend Biotech's median Non-Current Deffered Revenue value was -$188000.0 (recorded in 2021), while the average stood at $2.8 million.
  • As far as peak fluctuations go, Legend Biotech's Non-Current Deffered Revenue tumbled by 15877.19% in 2021, and later surged by 1861.11% in 2024.
  • Quarter analysis of 5 years shows Legend Biotech's Non-Current Deffered Revenue stood at -$295000.0 in 2021, then increased by 20.68% to -$234000.0 in 2022, then soared by 20596.58% to $48.0 million in 2023, then tumbled by 100.9% to -$430000.0 in 2024, then soared by 35.58% to -$277000.0 in 2025.
  • Its Non-Current Deffered Revenue was -$277000.0 in Q2 2025, compared to -$134000.0 in Q1 2025 and -$430000.0 in Q3 2024.